Impact of time to treatment on the effects of bivalirudin vs. glycoprotein IIb/IIIa inhibitors and heparin in patients undergoing primary percutaneous coronary intervention: Insights from the HORIZONS-AMI trial

Mikkel M. Schoos, Giuseppe De Luca, George D. Dangas, Peter Clemmensen, Girma Minalu Ayele, Roxana Mehran, Gregg W. Stone

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Impact of time to treatment on the effects of bivalirudin vs. glycoprotein IIb/IIIa inhibitors and heparin in patients undergoing primary percutaneous coronary intervention: Insights from the HORIZONS-AMI trial'. Together they form a unique fingerprint.

Keyphrases

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science